On March 24, 2025, Tikvah Management LLC, which owns approximately 1.5% of Quanterix Corp.'s outstanding common shares, announced its intention to vote AGAINST the company’s proposed merger with Akoya Biosciences, Inc. at the upcoming Quanterix Special Meeting of shareholders.
Tikvah, a significant investor since 2018, stated its belief that the proposed merger is not in the best interest of Quanterix’s shareholders. The firm echoed public comments from other investors opposing the merger, citing concerns about the undervaluation of Quanterix shares.
Additional reasons for opposition included a projected significant reduction in Quanterix’s cash runway post-merger and the belief that Quanterix’s business is superior to Akoya’s. Tikvah reserved the right to change its intention based on significant new developments.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.